Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance

BACKGROUND: Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicholson, Suellen, Karapanagiotidis, Theo, Khvorov, Arseniy, Douros, Celia, Mordant, Francesca, Bond, Katherine, Druce, Julian, Williamson, Deborah A, Purcell, Damian, Lewin, Sharon R, Sullivan, Sheena, Subbarao, Kanta, Catton, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136026/
https://www.ncbi.nlm.nih.gov/pubmed/34258311
http://dx.doi.org/10.1093/ofid/ofab239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136026/
https://www.ncbi.nlm.nih.gov/pubmed/34258311
http://dx.doi.org/10.1093/ofid/ofab239

Ejemplares similares